• Home
  • Science General
  • Advances in Nuclear Oncology: Diagnosis and Therapy by Emilio Bombardieri, John Buscombe, Giovanni Lucignani, Otmar

Advances in Nuclear Oncology: Diagnosis and Therapy by Emilio Bombardieri, John Buscombe, Giovanni Lucignani, Otmar

By Emilio Bombardieri, John Buscombe, Giovanni Lucignani, Otmar Schober

Nuclear imaging is more and more required to enquire complicated medical difficulties and to lead healing intervention. the main generic nuclear agent is FDG, and while FDG puppy is mixed with CT, the nuclear medication doctor and oncologist own crucial software certainly. the head caliber pictures which are bought express beautiful anatomical and morphological aspect. Advances in Oncologic medication offers the reader with crucial heritage details and a wealth of illustrative fabric to make sure speedy affliction development attractiveness.

Show description

Read or Download Advances in Nuclear Oncology: Diagnosis and Therapy PDF

Similar science (general) books

Extra resources for Advances in Nuclear Oncology: Diagnosis and Therapy

Example text

Chen X, Park R, Shahinian AH et al. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol 2004; 31: 179–89. 25. Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997; 15: 542–6. 26. Blasberg RG, Roelcke U, Weinreich R et al. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine. Cancer Res 2000; 60: 624–35. 27. Carnochan P, Brooks R. Radiolabelled 5′-iodo-2′-deoxyuridine: a promising alternative to [18F]-2-fluoro-2-deoxy-Dglucose for PET studies of early response to anticancer treatment.

Chen X, Park R, Shahinian AH et al. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol 2004; 31: 179–89. 25. Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997; 15: 542–6. 26. Blasberg RG, Roelcke U, Weinreich R et al. Imaging brain tumor proliferative activity with [124I]iododeoxyuridine. Cancer Res 2000; 60: 624–35. 27. Carnochan P, Brooks R. Radiolabelled 5′-iodo-2′-deoxyuridine: a promising alternative to [18F]-2-fluoro-2-deoxy-Dglucose for PET studies of early response to anticancer treatment.

In addition to surgical resection, treatment is based on craniospinal radiotherapy to prevent leptomeningeal dissemination through cerebrospinal fluid. 20 Ependymomas are commonly diagnosed in children under 4 years of age, but they occur also in adults at any age. They usually arise in the ependymal lining of the ventricles and may occur anywhere within the CNS. Most frequently they lie within the posterior fossa arising from the lining of the fourth ventricle or cerebellopontine angle, but they may also arise in the filum terminale and the central spinal canal.

Download PDF sample

Rated 4.19 of 5 – based on 33 votes